Current understanding of pathogenesis of dry AMD still unsatisfactory
New stem cell treatment approaches entering clinical studies
Leigh Spielberg
Published: Wednesday, January 25, 2017
What we are working towards is based on the cataract surgery model, with a preloaded transplantation patch populated with an easily accessible cell sourceA large trial with a porcine model has been completed, and a phase I trial has begun in Moorfields Eye Hospital. “Previous RPE transplantation or macular translocation techniques have always used ‘old’ RPE,” said Prof da Cruz. “Here, we’re placing the overlying retina on brand new RPE. This is what we mean when we talk about regenerative medicine.” Prof da Cruz showed optical coherence tomography images of a successfully placed subretinal RPE patch with a very normal-appearing retina, including a near-physiological foveal depression, overlying it. The images seemed to give hope to delegates that they might some day be able to offer their patients a beneficial treatment option for dry AMD. Lyndon da Cruz: lyndon.dacruz@moorfields.nhs.uk
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.
Reversible Multifocality
Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.
Managing a Cataract Surgery Refractive Miss
Weighing the pros and cons of options for intraocular intervention.
Unleashing OCT’s Full Potential
Performance of newest tool for corneal evaluation meets or beats older standard technologies.